Global, Regional, and National Temporal Trend and Patterns of Change in the Burden of Asthma From 1990 to 2021: An Analysis of the Global Burden of Disease Study 2021
- PMID: 40186501
- DOI: 10.1111/1440-1681.70039
Global, Regional, and National Temporal Trend and Patterns of Change in the Burden of Asthma From 1990 to 2021: An Analysis of the Global Burden of Disease Study 2021
Abstract
Background: Asthma presents a significant challenge to the global healthcare systems and imposes a heavy socioeconomic burden. Previous studies had geographical limitations and lacked comprehensive global analysis. The study utilises data from the 2021 Global Burden of Disease (GBD) study to assess the global, regional, and national burden of asthma from 1990 to 2021. It examines disease trends, highlights health inequalities and aims to provide scientific evidence for future public health strategies and the optimisation of resource allocation.
Methods: Data from GBD 2021 were used to estimate the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of asthma across 21 global regions and 204 countries and territories from 1990 to 2021. Temporal trends were analysed, and the relationship between asthma burden and the socio-demographic index (SDI) was examined using a smoothing spline model. Analyses included the slope index of inequality and the concentration index to assess health disparities, frontier analysis to estimate achievable outcomes based on development levels, and decomposition analysis to identify the drivers of changes in DALYs number.
Results: Over the past three decades, the age-standardised burden of asthma has declined, with age-standardised mortality and DALY rates decreasing by 46% and 44%, respectively. However, the absolute number of deaths has increased by 17%, particularly among females, especially in low and low-middle SDI regions. Significant health inequalities persist, with high-SDI regions benefiting from better asthma control, while low-SDI regions face disproportionate burdens due to healthcare disparities. Frontier analysis highlights gaps between current and optimal disease burden levels, while low-SDI regions require increased investment in asthma control. Aging, population growth, and epidemiological changes are key drivers of asthma burden trends. High body mass index (BMI) remains the leading risk factor, while smoking and occupational exposures continue to contribute significantly.
Conclusions: The global burden of asthma has declined, yet significant regional disparities persist, with low-SDI regions experiencing higher mortality and DALYs due to limited healthcare access and environmental risks. High BMI, smoking and occupational exposures remain key contributors, requiring targeted public health interventions and lifestyle modifications.
Keywords: asthma; disability‐adjusted life years; epidemiology; global burden of disease; mortality; socio‐demographic index.
© 2025 John Wiley & Sons Australia, Ltd.
Similar articles
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496105 Free PMC article.
-
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8. Lancet. 2024. PMID: 38762325 Free PMC article.
-
Global, regional, and national burden of acute leukemia and its risk factors from 1990 to 2021 and predictions to 2040: findings from the global burden of disease study 2021.Biomed Eng Online. 2025 Jun 10;24(1):72. doi: 10.1186/s12938-025-01403-7. Biomed Eng Online. 2025. PMID: 40495176 Free PMC article.
-
Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.Lancet Respir Med. 2025 May;13(5):425-446. doi: 10.1016/S2213-2600(25)00003-7. Epub 2025 Mar 24. Lancet Respir Med. 2025. PMID: 40147466
-
Global burden of motor neuron disease: unraveling socioeconomic disparities, aging dynamics, and divergent future trajectories (1990-2040).J Neurol. 2025 May 11;272(6):390. doi: 10.1007/s00415-025-13130-z. J Neurol. 2025. PMID: 40349275 Free PMC article. Review.
Cited by
-
The study for asthma in older adults: a combined analysis of the effects of occupational asthmagens, high body-mass index and smoking.Front Public Health. 2025 Jul 23;13:1625623. doi: 10.3389/fpubh.2025.1625623. eCollection 2025. Front Public Health. 2025. PMID: 40771251 Free PMC article.
References
-
- G. B. D. Diseases and C. Injuries, “Global Incidence, Prevalence, Years Lived With Disability (YLDs), Disability‐Adjusted Life‐Years (DALYs), and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990‐2021: A Systematic Analysis for the Global Burden of Disease Study 2021,” Lancet 403, no. 10440 (2024): 2133–2161.
-
- J. M. Ramsahai, P. M. Hansbro, and P. A. B. Wark, “Mechanisms and Management of Asthma Exacerbations,” American Journal of Respiratory and Critical Care Medicine 199, no. 4 (2019): 423–432.
-
- E. D. Bateman, S. S. Hurd, P. J. Barnes, et al., “Global Strategy for Asthma Management and Prevention: GINA Executive Summary,” European Respiratory Journal 31, no. 1 (2008): 143–178.
-
- K. Tang, J. Huang, S. Xie, et al., “Temporal Trend in Burden of Asthma in China, South Korea, and Japan, 1990‐2019: Results From the Global Burden of Disease Study 2019,” Journal of Thoracic Disease 15, no. 5 (2023): 2559–2570.
-
- E. D. Bateman, H. A. Boushey, J. Bousquet, et al., “Can Guideline‐Defined Asthma Control Be Achieved? The Gaining Optimal Asthma ControL Study,” American Journal of Respiratory and Critical Care Medicine 170, no. 8 (2004): 836–844, https://doi.org/10.1164/rccm.200401‐033OC.
MeSH terms
Grants and funding
- 82274263/National Natural Science Foundation of China
- 2022XD027/Shanghai Municipal Health Commission's Excellent Discipline Leader Training Program for Municipal Medical and Health Institutions
- 20234Z0018/Shanghai Health Commission's Excellence Project
- SHGZS-202228/Shanghai Famous Traditional Chinese Medicine Academic Experience Research Studio Construction Project
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous